Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).

Authors : Cannon Christopher P CP; Rhee Karen E KE; Califf Robert M RM; Boden William E WE; Hirsch Alan T AT; Alberts Mark J MJ; Cable Greg G; Shao Mingyuan M; Ohman E Magnus EM; Steg P Gabriel PG; Eagle Kim A KA; Bhatt Deepak L DL; ;

Affiliations : TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. cpcannon@partners.org

Journal : Am. J. Cardiol.   (2010)

Related Links: Pubmed | Publisher website

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

Authors : Steg PG; Alam S; Chiang CE; Gamra H; Goethals M; Inoue H; Krapf L; Lewalter T; Merioua I; Murin J; Naditch-Brûlé L; Ponikowski P; Rosenqvist M; Silva-Cardoso J; Zharinov O; Brette S; O Neill J;

Affiliations : Professeur Ph. Gabriel Steg, INSERM U-698 “Recherche Clinique en Athérothrombose” Université Paris VII - Denis Diderot, Assistance Publique - Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 PARIS Cedex 18, FRANCE; gabriel.steg@bch.aphp.fr

Journal : N/A   (2011)

Related Links: Pubmed | Publisher website

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry.

Authors : Steg PG; Alam S; Chiang CE; Gamra H; Goethals M; Inoue H; Krapf L; Lewalter T; Merioua I; Murin J; Naditch-Brûlé L; Ponikowski P; Rosenqvist M; Silva-Cardoso J; Zharinov O; Brette S; O Neill J;

Affiliations : Professeur Ph. Gabriel Steg, INSERM U-698 “Recherche Clinique en Athérothrombose” Université Paris VII - Denis Diderot, Assistance Publique - Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 PARIS Cedex 18, FRANCE; gabriel.steg@bch.aphp.fr

Journal : HEART and Education in Heart   (2011)

Related Links: Pubmed | Publisher website

Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF†

Authors :

Affiliations : General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital, National Yang-Ming University, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan Department of Cardiology-Electrophysiology, H.-Hartziekenhuis Roeselare-Menen, Wilgenstraat 2, Roeselare 8800, Belgium Connolly/Mater Hospitals/RCSI, Dublin 15/7/2, Ireland Sanofi, Paris 75008, France Lincoln, Boulogne-Billancourt 92517, France Department of Cardiology A, Cardiothrombosis Research Unit, Fattouma Bourguiba University Hospital, Monastir 5000, Tunisia National Medical Academy of Postgraduate Education, Kiev 04112, Ukraine INSERM U-698, Paris 75018, France Université Paris-Diderot, Paris 75013, France Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard, Paris 75018, France

Journal : N/A   (2013)

Related Links: Pubmed | Publisher website

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition a

Authors : Daniel Lindholm, MD; Agneta Siegbahn, MD, PhD; Lisa Wernroth, MSc; Richard C. Becker, MD; Christopher P. Cannon, MD; Jan H. Cornel, MD, PhD; Anders Himmelmann, MD, PhD; Evangelos Giannitsis, MD; Robert A. Harrington, MD; Claes Held, MD, PhD; Steen Husted, MD, DSc; Hugo A. Katus, MD; Kenneth W. Mahaffey, MD; Ph. Gabriel Steg, MD; Robert F. Storey, MD, DM; Stefan K. James, MD, PhD;

Affiliations : Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (L.W., D.L., L.W., C.H., S.K.J.); Department of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center Uppsala University, Uppsala, Sweden (A.S.); Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, Academic Health Center, Cincinnati, OH (R.C.B.); Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.P.C.); Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, Netherlands (J.H.C.); AstraZeneca Research and Development, Mölndal, Sweden (A.H.); Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany (E.G., H.A.K.); Medical Department, Hospital Unit West, Herning/Holstbro, Denmark (S.H.); INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, UK (P.G.S.); and Department of Cardiovascular Science, University of Sheffield, Sheffield, UK (R.F.S.).

Journal : N/A   (2014)

Related Links: Pubmed | Publisher website